Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

BioLineRx enters collaboration with Jiangsu Chia-tai Tianqing Pharmaceutical

June 11, 2013

First compound from Eisai and Quintiles' anticancer collaboration demonstrates proof of concept

June 10, 2013

Oculus Innovative Sciences enters into agreement with Ruthigen

June 10, 2013

Second Genome and Janssen enter microbiome drug discovery agreement

June 10, 2013

CytomX and Pfizer to develop Probody-Drug Conjugates for cancer

June 7, 2013

Genor Biopharma and BioCND to develop biosimilars of Humira and Herceptin

June 7, 2013

NB Health Laboratory and Mercachem expand partnership

June 6, 2013

Shionogi and TB alliance set to collaborate

June 6, 2013

GlaxoSmithKline to develop and commercialize MOR-103

June 5, 2013

Fujifilm and Dr. Reddy's cancel partnership for generic drugs in Japan

June 5, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...